Stocklytics Platform
Asset logo for symbol CC
Chemours
CC64
$10.43arrow_drop_down3.59%-$0.38
Asset logo for symbol CC
CC64

$10.43

arrow_drop_down3.59%

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Chemours (CC) Stocklytics Forecast

Chemours Co-The (CC) is a leading global provider of performance chemicals. The company operates in three segments: Titanium Technologies, Fluoroproducts, and Chemical Solutions. With a strong portfolio of products and a focus on innovation, Chemours is well-positioned for future growth. Investors are keen to know the stock price prediction for CC.
Forecasting stock prices is a complex task that involves analyzing various factors like market trends, company financials, industry outlook, and investor sentiment. While it is impossible to predict stock prices with absolute certainty, analysts and AI-powered models can provide insights into possible future trends.
add Chemours to watchlist

Keep an eye on Chemours

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Chemours (CC) stock?

Analysts have set a target price of $32.62 for Chemours (CC), based on forecasts from 26 analysts. The predicted price range extends from a high of $54 to a low of $19. This represents a potential increase of up to 417.49% and a decrease of 82.08% from the current price of $10.44. These forecasts are as of 2023 Feb 13.
help

What are the analyst ratings for Chemours (CC) stock?

The analyst ratings for Chemours (CC) are distributed as follows: 5 analysts recommend buying, 4 have a neutral stance, and 0 suggest selling. The prevailing sentiment among the total of 9 analysts leans towards a buy rating. These ratings indicate the general sentiment among the analysts covering Chemours.
help

What is the AI price prediction for Chemours (CC) stock?

At present, there is no AI or machine-learning-based price prediction available for Chemours (CC) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level